Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
OLIVE RESOURCE CAPITAL | DFU | Nov 26, 2024 | 0.02 | -3.23 |
Ollies Bargain Outlet Holdings, Inc. | OL6 | Nov 26, 2024 | 95.50 | +6.11 |
Olvi A | OVI | Nov 26, 2024 | 28.55 | +2.70 |
Olympic Steel, Inc. | OYS | Nov 26, 2024 | 39.40 | -1.99 |
Olympus Corp. | OLY1 | Nov 26, 2024 | 15.07 | +0.37 |
OLYMPUS CORP. ADR | OLY | Nov 26, 2024 | 14.50 | 0.00 |
Oma Säästöpankki | OM0 | Nov 26, 2024 | 10.92 | -1.97 |
Omai Gold Mines Corp | 0N2 | Nov 26, 2024 | 0.11 | -3.54 |
Omega Diagnostics Group Plc | RVKA | Nov 26, 2024 | 0.03 | 0.00 |
Omega Healthcare Investors, Inc. | WX4 | Nov 26, 2024 | 38.84 | +1.76 |
OMEGA PACIFIC RESOURCES | Q0F | Nov 26, 2024 | 0.16 | -7.56 |
Omer S.p.a | 9WR | Nov 26, 2024 | 4.16 | -0.95 |
Omer-Decugis & Cie | 0VC | Nov 26, 2024 | 4.44 | -0.67 |
Omeros Corporation | 3O8 | Nov 26, 2024 | 11.56 | +4.81 |
Omni Bridgeway Limited | MXG1 | Nov 26, 2024 | 0.62 | -1.59 |
Omnia Holdings Ltd | OHZ | Nov 26, 2024 | 3.76 | -2.59 |
Omnicell, Inc. | OC9 | Nov 26, 2024 | 43.40 | 0.00 |
Omnicom Group Inc. | OCN | Nov 26, 2024 | 98.34 | +0.63 |
OMV AG | OMV | Nov 26, 2024 | 38.12 | -0.52 |
OMV AG | OMVI | Nov 26, 2024 | 9.50 | -1.55 |
ON Semiconductor Corporation | XS4 | Nov 26, 2024 | 67.18 | +1.24 |
On the Beach Group plc | 9BP | Nov 26, 2024 | 1.90 | -1.55 |
Oncimmune Holdings plc | OCY | Nov 26, 2024 | 0.13 | -1.54 |
Oncoarendi Therapeutics SA | 1B1 | Nov 26, 2024 | 2.36 | +1.73 |
ONCODES.PREC.MED. EO-,34 | ZR8 | Nov 26, 2024 | 0.96 | -0.62 |
Onconova Therapeutics, Inc. | 0T2 | Nov 26, 2024 | 6.60 | 0.00 |
Oncopeptides | OND | Nov 26, 2024 | 0.07 | -2.10 |
Oncotherpapy Science Inc | 30O | Nov 26, 2024 | 0.15 | -3.90 |
OncoZenge | 8LY | Nov 26, 2024 | 0.33 | +13.00 |
ONDAS HLDGS INC. DL-,0001 | 1B8 | Nov 26, 2024 | 0.78 | -7.19 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.